Abattis Bioceuticals (Abattis Bioceuticals) Net Change in Cash : $-1.53 Mil (TTM As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Abattis Bioceuticals's Net Change in Cash for the three months ended in Sep. 2019 was $-0.51 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2019 was $-1.53 Mil.

Abattis Bioceuticals Net Change in Cash Historical Data

The historical data trend for Abattis Bioceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Net Change in Cash Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Net Change in Cash

Get a 7-Day Free Trial

0.02

-0.09

0.40

2.72

-1.55

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Net Change in Cash	Get a 7-Day Free Trial															-1.16	-1.06	0.77	-0.73	-0.51

Abattis Bioceuticals Net Change in Cash Calculation

Abattis Bioceuticals's Net Change in Cash for the fiscal year that ended in Sep. 2019 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	7.108	+	-8.698	+	0.045	+	0
	=	-1.55

Abattis Bioceuticals's Net Change in Cash for the quarter that ended in Sep. 2019

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 2.972 + -3.479 + 0 + 0

= -0.51

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abattis Bioceuticals Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Abattis Bioceuticals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Net Change in Cash

Comparable Companies

GSRX GENH PHBI MYHI APPB CNABQ OWCP CBDY CXUS RDGL ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (Abattis Bioceuticals) Headlines

From GuruFocus

Abattis Bioceuticals Announces Release of New Line of Vaporizers
By Marketwired Marketwired • 05-22-2018

Abattis Continues to Build on Recent Investments With Plans for Significant Revenue Growth
By Marketwired Marketwired • 07-31-2018

Abattis Provides Update on Trading Halt and Announces Management Conference Call
By Marketwired Marketwired • 02-18-2019

Abattis Provides Update on Conference Call
By Marketwired Marketwired • 02-28-2019

Abattis Announces Share Buy Back Program
By Marketwired Marketwired • 08-07-2018

Abattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons
By PRNewswire PRNewswire • 11-28-2018

Abattis Retains Canadian and American Compliance Agency and Provides Company Update
By Marketwired Marketwired • 11-21-2018

Abattis Announces Acquisition of Fertilizer Company NutriVida
By Marketwired Marketwired • 12-08-2018

Abattis Bioceuticals Provides Update on Vaporizer Product Line
By Marketwired Marketwired • 10-12-2018

Abattis Bioceuticals Expanding Downstream Cannabis Business into Ontario -- CFN Media
By Marketwired Marketwired • 07-24-2018